CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Retained Earnings Cumulative effect of change in accounting principle - Current Expected Credit Losses	[1]	Retained Earnings	Unallocated Common Stock of ESOP	Accumulated Other Comprehensive Income (Loss)	Cumulative effect of change in accounting principle - Current Expected Credit Losses	[1]	Total
Balance at beginning of period at Jun. 30, 2022	$ 260	$ 113,713			$ 151,090	$ (11,256)	$ (11,180)			$ 242,627
Balance at beginning of period (in shares) at Jun. 30, 2022	25,977,679
Increase (Decrease) in Shareholder's Equity
Net income					21,948					21,948
Other comprehensive income							1,612			1,612
ESOP shares committed to be released (shares)		(170)				683				513
Balance at end of period at Jun. 30, 2023	$ 260	113,543	$ 507		173,038	(10,573)	(9,568)	$ 507		$ 266,700
Balance at end of period (in shares) at Jun. 30, 2023	25,977,679									25,977,679
Increase (Decrease) in Shareholder's Equity
Net income										$ 6,611
Other comprehensive income										9,749
Balance at end of period at Dec. 31, 2023							181
Balance at beginning of period at Jun. 30, 2023	$ 260	113,543	$ 507		173,038	(10,573)	(9,568)	$ 507		$ 266,700
Balance at beginning of period (in shares) at Jun. 30, 2023	25,977,679									25,977,679
Increase (Decrease) in Shareholder's Equity
Net income					15,260					$ 15,260
Other comprehensive income							14,510			14,510
ESOP shares committed to be released (shares)		(209)				681				472
Stock-based compensation expense		154								154
Restricted stock awards granted	$ 4	(4)
Restricted stock awards granted (in shares)	390,000
Repurchases of common stock	$ (1)				(1,074)					(1,075)
Repurchases of common stock (in shares)	(106,386)
Balance at end of period at Jun. 30, 2024	$ 263	113,484			187,731	(9,892)	4,942			$ 296,528
Balance at end of period (in shares) at Jun. 30, 2024	26,261,293									26,261,293
Increase (Decrease) in Shareholder's Equity
Net income					9,600					$ 9,600
Other comprehensive income							601			601
ESOP shares committed to be released (shares)		(58)				341				283
Stock-based compensation expense		687								687
Restricted stock awards granted (in shares)	5,000
Repurchases of common stock	$ (3)				(3,143)					(3,146)
Repurchases of common stock (in shares)	(287,389)
Balance at end of period at Dec. 31, 2024	$ 260	$ 114,113			$ 194,188	$ (9,551)	$ 5,543			$ 304,553
Balance at end of period (in shares) at Dec. 31, 2024	25,978,904									25,978,904

[1] Additional